MedStar Health considers External Counterpulsation Therapy (ECP) medically necessary for the following indications:

Similar documents
Premier Health Plan considers Intravascular Ultrasound (IVUS) for Coronary Vessels medically necessary for the following indications:

MedStar Health considers Continuous Home Pulse Oximetry medically necessary for the following indications:

MedStar Health considers Cough Assist Devices medically necessary for the following indications:

Subject: External Counterpulsation (ECP)

MEDICAL POLICY SUBJECT: ENHANCED EXTERNAL COUNTERPULSATION

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: MP.103.MH Last Review Date: 11/08/2018 Effective Date: 02/01/2019

Corporate Medical Policy

MP.094.MH Transcutaneous Electrical Nerve Stimulators

MedStar Health considers Septoplasty-Rhinoplasty medically necessary for the following indications:

Premier Health Plan considers Negative Pressure Wound Therapy (NPWT) in the home setting medically necessary for the following indications:

Outpatient Cardiac Rehabilitation

MP.090.MH Nerve Block, Paravertebral, Facet Joint, and SI Injections

Clinical Policy Title: Cardiac rehabilitation

Clinical Policy: Cardiac Biomarker Testing for Acute Myocardial Infarction Reference Number: CP.MP.156

Premier Health Plan considers Iontophoresis for Musculoskeletal Conditions medically necessary for the following indications:

Cardiac Rehabilitation

Enhanced External Counterpulsation (EECP)

Clinical Policy Title: External counterpulsation therapy

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: PA.010.MH Last Review Date: 05/11/2017 Effective Date: 07/01/2017

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012

Premier Health Plan considers Oral Appliances for Obstructive Sleep Apnea (OSA) medically necessary for the following indications:

Clinical Policy: Heart-Lung Transplant Reference Number: CP.MP.132

Populations Interventions Comparators Outcomes Individuals: With diagnosed heart disease. rehabilitation

Clinical Policy Title: External counterpulsation (ECP) therapy

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: MP.066.MH Last Review Date: 11/08/2018 Effective Date: 01/01/2019

Blepharoptosis repair is covered as functional/reconstructive surgery to correct: Visual impairment due to droop or displacement of the upper lid.

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: PA.017.MH Last Review Date: 08/04/2016 Effective Date: 01/01/2016

11/19/2013. Cardiac Rehabilitation Coverage and Documentation Requirements. Phases of Cardiac Rehabilitation. Phase II

Acute Coronary Syndrome

Policy #: 059 Latest Review Date: January 2014

Enhanced External Counterpulsation

Enhanced External Counterpulsation

Clinical Policy: Total Artificial Heart Reference Number: CP.MP.127

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: PA.018.MH Last Review Date: 08/04/2016 Effective Date: 01/01/2017

Clinical Policy: Microvolt T-Wave Alternans Testing Reference Number: CP.MP.212

MEDICAL POLICY SUBJECT: CARDIAC REHABILITATION. POLICY NUMBER: CATEGORY: Therapy/ Rehabilitation

2019 ABBOTT REIMBURSEMENT GUIDE CMS Physician Fee Schedule

Clinical Policy: Ultrafiltration for Heart Failure Reference Number: CP.MP.456

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL

Medical Policy and and and and

Clinical Policy: Robotic Surgery Reference Number: CP.MP. 207

Clinical Policy: Fecal Calprotectin Assay Reference Number: CP.MP.135

Transmyocardial Revascularization

Original Policy Date

MEDICAL POLICY SUBJECT: CARDIAC REHABILITATION

POLICIES AND PROCEDURE MANUAL

MEDICAL POLICY SUBJECT: TRANSMYOCARDIAL REVASCULARIZATION

VENTRICULAR ASSIST DEVICES AND TOTAL ARTIFICIAL HEARTS

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

OP Chest Pain General Data Element List. All Records All Records. All Records All Records All Records. All Records. All Records.

Clinical Policy: DNA Analysis of Stool to Screen for Colorectal Cancer

Clinical Policy: Cochlear Implant Replacements Reference Number: CP.MP.14

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

Clinical Policy: Heart-Lung Transplant Reference Number: CP.MP.132

External Counterpulsation

See Important Reminder at the end of this policy for important regulatory and legal information.

Enhanced External Counterpulsation (EECP)

The Counter HF Clinical Study for Heart Failure

Clinical Policy: Cochlear Implant Replacements

MEDICAL POLICY SUBJECT: CARDIAC REHABILITATION. POLICY NUMBER: CATEGORY: Therapy/ Rehabilitation

CHRONIC HEART FAILURE : WHAT ELSE COULD WE OFFER TO OUR PATIENTS? Cardiac Rehabilitation Society of Thailand

Clinical Policy: Trigger Point Injections for Pain Management

Enhanced External Counterpulsation. Description

Clinical Policy: Oxygen Therapy in the Home Reference Number: CP.MP.485

Clinical Policy: Digital Breast Tomosynthesis Reference Number: CP.MP.90

Clinical Policy: Implantable Miniature Telescope for Age Related Macular Degeneration Reference Number: CP.MP.517

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Clinical Policy: Electric Tumor Treating Fields (Optune) Reference Number: CP.MP.145

Clinical Policy: Essure Removal Reference Number: CP.MP.131

Pulmonary Hypertension Drugs

Clinical Policy: Ventricular Assist Devices Reference Number: CP.MP.46

Local Coverage Determination (LCD) for Cardiac Catheterization (L29090)

MEDICAL POLICY Cardiac Event Monitors/ Cardiac Event Detection

Clinical Policy: Digital EEG Spike Analysis

DUKECATHR Dataset Dictionary

CMS Limitations Guide - Cardiovascular Services

POLICIES AND PROCEDURE MANUAL

Clinical Policy: Gastric Electrical Stimulation Reference Number: CP.MP.40

MEDICAL POLICY. Proprietary Information of Excellus Health Plan, Inc. A nonprofit independent licensee of the BlueCross BlueShield Association

Improving cardiovascular disease one heartbeat at a time.

Common Codes for ICD-10

TRANSMYOCARDIAL REVASCULARIZATION

Clinical Policy: Tadalafil (Adcirca) Reference Number: CP.PHAR.198

CY2015 Hospital Outpatient: Endovascular Procedure APCs and Complexity Adjustments

Clinical Policy: Macitentan (Opsumit) Reference Number: ERX.SPMN.88

Contractor Information

Clinical Policy: Pediatric Heart Transplant

CLINICAL MEDICAL POLICY

Contractor Information. LCD Information. Local Coverage Determination (LCD): Cardiac Rehabilitation (L34412) Document Information

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines)

Product Name or Headline

CORONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW

Implantable Ventricular Assist Devices and Total Artificial Hearts. Policy Specific Section: June 13, 1997 March 29, 2013

Transmyocardial Revascularization

Automatic External Defibrillators

Clinical Policy: Ambrisentan (Letairis) Reference Number: CP.PHAR.190

Transmyocardial Revascularization. Description

Chapter 4 Section 9.1

Transcription:

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL MP.107.MH External Counterpulsation Therapy This policy applies to the following lines of business: MedStar Employee (Select) MedStar MA DSNP CSNP MedStar CareFirst PPO MedStar Health considers External Counterpulsation Therapy (ECP) medically necessary for the following indications: An initial full course (35 one hour treatments per benefit period, which may be offered once or twice daily, usually five days per week) of ECP therapy is considered medically necessary only for the following: Members with a diagnosis of chronic disabling stable angina Class III or IV per New York Heart Association (NYHA) or Canadian Cardiovascular Society (CCS) refractory to maximum medical therapy and not amenable to surgical intervention (in the opinion of a cardiologist or cardiothoracic surgeon) such as percutaneous transluminal coronary angioplasty (PTA) or cardiac bypass because of one of the following: Their condition is inoperable or at high risk of operative complications or post-op failure; Or Their coronary anatomy is not amenable for such procedures; Or They have co-morbid states which could create excessive risk. Repeat courses of ECP will be considered on a case by case basis for persons with chronic stable angina if all of the following criteria are met: Member meets medical necessity criteria for ECP; And Prior ECP has resulted in a sustained improvement in symptoms, with a significant (greater than 25%) reduction in frequency of angina symptoms; Or Improvement by one or more angina classes (NYHA or CCS); And Three or more months has elapsed from the prior ECP treatment. Limitations This policy only addresses ECP performed in the outpatient setting

All other cardiac conditions not otherwise specified as nationally covered for the use of ECP remain nationally non-covered Must be performed under the direct supervision of a physician who must be present and immediately available to provide assistance and direction during the treatment FDA approved ECP devices intended for the treatment of cardiac conditions Hydraulic versions of ECP devices will not be covered ECP is not intended as a first-line therapy for angina ECP is not covered for member with any of the following conditions: Arrhythmias that interfere with machine triggering Active thrombophlebitis Severe lower extremity vaso-occlusive disease Presence of a documented aortic aneurysm requiring surgical repair Pregnancy Background The Centers for Medicare and Medicaid Services (CMS) define external counterpulsation (ECP) as a noninvasive outpatient treatment for coronary artery disease refractory to medical and/or surgical therapy. ECP is also commonly referred to as enhanced external counterpulsation. The patient is placed on a treatment table where their lower trunk and lower extremities are wrapped in a series of three compressive air cuffs which inflate and deflate in synchronization with the patient's cardiac cycle. Although ECP devices are cleared by the Food and Drug Administration (FDA) for use in treating a variety of cardiac conditions, including stable or unstable angina pectoris, acute myocardial infarction and cardiogenic shock, the use of this device to treat cardiac conditions other than stable angina pectoris is not covered, since only that use has developed sufficient evidence to demonstrate its medical effectiveness. Non-coverage of hydraulic versions of these types of devices remains in force. New York Heart Association Grading Scale for Heart Failure: - Class I: No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea (shortness of breath). - Class II: Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea. - Class III: Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea. Page 2 of 5

- Class IV: Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases. Canadian Cardiovascular Society Grading Scale for Angina: - Class I: Ordinary physical activity does not cause angina, such as walking or climbing stairs. Angina occurs with strenuous, rapid or prolonged exertion. - Class II: Slight limitation of ordinary activity. Angina occurs only during vigorous physical activity, such as walking or climbing stairs rapidly, walking uphill, walking or stair climbing after meals in cold, wind, or under emotional stress, or only during the few hours after awakening. Walking more than two blocks on the level and climbing more than one flight of ordinary stairs at a normal pace and in normal conditions - Class III: Marked limitation of ordinary physical activity. It is induced by walking one or two level blocks and climbing one flight of stairs in normal conditions and at a normal pace - Class IV: Inability to carry on any physical activity without discomfort. Anginal syndrome may be present at rest. Codes: CPT Codes / HCPCS Codes / ICD-10 Codes Code Description HCPCS codes covered if selection criteria are met (If Appropriate): G0166 External Counterpulsation, per treatment session ICD-9 codes covered if selection criteria are met: 413.0-413.9 Angina pectoris (disabling, refractory to maximum medical therapy and not readily amenable to surgical intervention ICD-10 codes covered if selection criteria are met: I20.0 Unstable angina I20.1 Angina pectoris with documented spasm I20.8 Other forms of angina pectoris I20.9 Angina pectoris, unspecified References Page 3 of 5

1. American Heart Association (AHA). Classes of Heart Failure. Last reviewed 04/06/215. http://www.heart.org/heartorg/conditions/heartfailure/aboutheartfailure/cla sses-of-heart-failure_ucm_306328_article.jsp#.vjeftlerrhe 2. Centers for Medicare and Medicaid Services (CMS). National Coverage Determination (NCD) No. 20.20 - External Counterpulsation Therapy for Severe Angina. Effective Date: 03/20/2006. http://www.cms.gov/medicare-coveragedatabase/details/ncddetails.aspx?ncdid=97&ncdver=2&bc=agaagaaaaaaaaa%3d%3d& 3. Centers for Medicare and Medicaid Services (CMS). Decision Memo for External Counterpulsation (ECP) Therapy (CAG-00002R2). March 20, 2006. https://www.cms.gov/medicare-coverage-database/details/nca-decisionmemo.aspx?ncaid=162&ver=21&ncaname=external+counterpulsation+(ecp) +Therapy+(2nd+Recon)&bc=BEAAAAAAEAAA&&fromdb=true 4. Hayes Medical Technology Directory. External Counterpulsation. Annual Review June 25, 2012. 5. Ischemia Trial Apendix I: New York Heart Association Grading Scale for Heart Failure and Canadian Cardiovascular Society Grading Scale for Angina. July 24, 2012. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=10&cad=rja &uact=8&ved=0cfqqfjajahukewigmrcy1uxiahxgwsykhzdwdm4&url=http s%3a%2f%2fischemiatrial.org%2fmoo%2fappendixi%2fappendix_nyha_ccs_grading_scale_jul.24.2012.pdf%2fat_download%2 Ffile&usg=AFQjCNGHJC-- 0gcNO46aqzxEyVyna5RWaA&sig2=wxePHHlFYeCfLrTfVx232w 6. Jneid H, Anderson JL, Wright RS, et al. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-st-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Jun 11;61(23):e179-347. doi: 10.1016/j.jacc.2013.01.014. Epub 2013 Apr 29. http://circ.ahajournals.org/content/early/2013/04/29/cir.0b013e31828478ac.full. pdf 7. McKenna C, McDaid C, Suekarran S, et al. Enhanced external counterpulsation for the treatment of stable angina and heart failure: a systematic review and economic analysis. Health Technol Assess. 2009; 13(24): iii-iv, ix-xi, 1-90. doi: 10.3310/hta13240. http://www.ncbi.nlm.nih.gov/pubmedhealth/pmh0015045/ 8. Snow V, Barry P, Fihn SD, et al. Primary care management of chronic stable angina and asymptomatic suspected or known coronary artery disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2004 Oct 5;141(7):562-567. http://annals.org/article.aspx?articleid=717863 Page 4 of 5

Disclaimer: MedStar Health medical payment and prior authorization policies do not constitute medical advice and are not intended to govern or otherwise influence the practice of medicine. The policies constitute only the reimbursement and coverage guidelines of MedStar Health and its affiliated managed care entities. Coverage for services varies for individual members in accordance with the terms and conditions of applicable Certificates of Coverage, Summary Plan Descriptions, or contracts with governing regulatory agencies. MedStar Health reserves the right to review and update the medical payment and prior authorization guidelines in its sole discretion. Notice of such changes, if necessary, shall be provided in accordance with the terms and conditions of provider agreements and any applicable laws or regulations. These policies are the proprietary information of Evolent Health. Any sale, copying, or dissemination of said policies is prohibited. Page 5 of 5